<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJNeph</journal-id><journal-title-group><journal-title>Open Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2164-2842</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojneph.2021.112017</article-id><article-id pub-id-type="publisher-id">OJNeph-109366</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Profile of Urinary Tract Infections in the Elderly in the Internal Medicine Department of the University Hospital Center of Point G, Bamako, Mali
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Drissa</surname><given-names>Sangaré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Magara</surname><given-names>Samaké</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nanko</surname><given-names>Doumbia</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aboubacar</surname><given-names>Sidiki Fofana</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sékou</surname><given-names>Mamadou Cissé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Seydou</surname><given-names>Sy</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Atabième</surname><given-names>Kodio</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moctar</surname><given-names>Coulibaly</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sah</surname><given-names>dit Baba Coulibaly</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djibril</surname><given-names>Sy</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kaya</surname><given-names>Assétou Soucko</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Dembélé</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Saharé</surname><given-names>Fongoro</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff6"><addr-line>Nephrology Unit of Somino Dolo Hospital, Mopti, Mali</addr-line></aff><aff id="aff8"><addr-line>Faculty of Medicine of Bamako, Bamako, Mali</addr-line></aff><aff id="aff5"><addr-line>Nephrology Unit of Mali Gavardo Hospital, Bamako, Mali</addr-line></aff><aff id="aff3"><addr-line>Medicine Department of Mali Hospital, Bamako, Mali</addr-line></aff><aff id="aff2"><addr-line>Nephrology Unit of Fousseyni Daou Hospital, Kayes, Mali</addr-line></aff><aff id="aff7"><addr-line>Internal Medicine Department of the University Hospital Center of Point G, Bamako, Mali</addr-line></aff><aff id="aff4"><addr-line>Nephrology Department of the University Hospital Center of Point G, Bamako, Mali</addr-line></aff><aff id="aff1"><addr-line>Department of Medicine and Medical Specialty, The Fousseyni Daou Hospital, Kayes, Mali</addr-line></aff><pub-date pub-type="epub"><day>23</day><month>04</month><year>2021</year></pub-date><volume>11</volume><issue>02</issue><fpage>217</fpage><lpage>229</lpage><history><date date-type="received"><day>15,</day>	<month>April</month>	<year>2021</year></date><date date-type="rev-recd"><day>23,</day>	<month>May</month>	<year>2021</year>	</date><date date-type="accepted"><day>26,</day>	<month>May</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Urinary tract infections (UTI) are frequent and of polymorphous clinical symptomatology in elderly subjects both in and out of hospital. In Mali, to our knowledge, no study concerning UTIs in the elderly has been conducted, hence the interest in this innovative work. 
  Objectives: To determine the prevalence and clinical and paraclinical aspects of urinary tract infections in the elderly. 
  Materials and Methods: This was a prospective descriptive and cross-sectional study from September 1, 2013 to August 31, 2014, 
  i.e.  duration of 12 months. All patients aged 65 years and over, hospitalized or ambulatory in the internal medicine department with a documented urinary tract infection were included. 
  Results: We collected and examined 194 patients. The cytobacteriological study of urine (CBSU) was positive in 28 patients, 
  i.e.  a prevalence of 14.43%. The male sex represented 59.8% of the cases, the sex ratio was equal to 1.46. The age groups between 65 - 69 and 70 - 74 years were the most affected, respectively 28.57% and 39.28%. The main clinical signs were: asthenia, anorexia, dependence, fever, urinary burning, dysuria. Hospitalization was associated with urinary tract infection with P = 0.01. The group of enterobacteria were incriminated in 75% of cases. 
  Escherichia coli, Klebsiella pneumoniae and 
  Pseudomonas aeruginosa represented 39.28%, 14.28% and 10.71% of cases. Urinary tract infections were represented by pyelonephritis, acute prostatitis, orchi-epididymitis and simple cystitis. 
  Conclusion: Urinary tract infection is frequent in the elderly, its clinical presentation is polymorphic and enterobacteria are the most incriminated group of bacteria.
 
</p></abstract><kwd-group><kwd>Urinary Tract Infection</kwd><kwd> Elderly Subject</kwd><kwd> Internal Medicine</kwd><kwd> Point G Hospital</kwd><kwd> Mali</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Urinary tract infections (UTI) are frequent and of polymorphous clinical symptomatology in elderly subjects both in and out of hospital [<xref ref-type="bibr" rid="scirp.109366-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref3">3</xref>]. In the community, they rank second after bronchial and pulmonary infections [<xref ref-type="bibr" rid="scirp.109366-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref5">5</xref>]. In the hospital setting, they rank first [<xref ref-type="bibr" rid="scirp.109366-ref3">3</xref>]. They are a public health problem both in terms of management and cost and are a daily problem [<xref ref-type="bibr" rid="scirp.109366-ref6">6</xref>]. They are the most frequently treated bacterial infections in the elderly in institutions [<xref ref-type="bibr" rid="scirp.109366-ref7">7</xref>]. In the city, the prevalence of urinary tract infections is estimated at 140/1000 in women over 75 years of age and at 50/1000 in men [<xref ref-type="bibr" rid="scirp.109366-ref8">8</xref>]. This difference in prevalence is historically explained by the greater distance between the urethral meatus and the anus in men, a drier environment at the urethral opening, a longer urethra and antibacterial activity of prostatic secretions [<xref ref-type="bibr" rid="scirp.109366-ref9">9</xref>].</p><p>In Tunisia, the prevalence of UTI in the Internal Medicine Department of Habib Thameur Hospital between January 2002 and December 2006 was 16.6%. It seems to be higher in elderly subjects than in those under 65 years of age with 35.2% and 17.9% respectively [<xref ref-type="bibr" rid="scirp.109366-ref2">2</xref>].</p><p>In Morocco, the prevalence rate of urinary tract infections at the Military Hospital Instruction Mohamed V in Rabat is 17.49%, i.e. 7.18% among outpatients and 10.31% among inpatients over 65 years of age [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>].</p><p>In Mali, to our knowledge no study concerning UTI in the elderly specifically has been conducted hence the interest of this study.</p><p>The objectives of this study were to determine the prevalence and the clinical and paraclinical aspects of urinary tract infections in the elderly.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>This was a prospective, descriptive, cross-sectional study from September 1, 2013 to August 31, 2014, i.e. duration of 12 months. Were included, all patients aged 65 years and over, hospitalized or outpatient in the department of Internal Medicine presenting a documented urinary tract infection.</p><p>For each patient, the interrogation allowed to note on an individual survey form the following data:</p><p>- Functional complaints: alteration of the general state, fever, agitation, delirium and incoherent speech, constipation, diarrhea, vomiting, pollakiuria, polyuria, urinary incontinence, suprapubic and or lumbar pain.</p><p>- Physical signs: large kidneys (lumbar contact), suprapubic and lumbar pain, bladder globe, prostate hypertrophy—Complementary tests: CBC, ESR, CRP, blood glucose, creatinine, CBSU (cytological and bacteriological study of urine), uroculture, antibiotic susceptibility test, blood culture, abdomino-pelvic ultrasound, abdomino-pelvic scanner.</p><p>- History: Hypertension, Diabetes, HIV, surgery on the urinary tract: kidneys, ureters, prostate, bladder.</p><p>Operational definitions:</p><p>- Urinary tract infection: positive urine cytobacteriological examination associated with at least one of the following signs;</p><p>- Temperature ≥ 38.5˚C or hypothermia ≤ 36.5˚C;</p><p>- Dysuria;</p><p>- Pollakiuria;</p><p>- Burning of the bladder;</p><p>- Suprapubic tension;</p><p>- Recent urinary incontinence;</p><p>- Drowsiness, onset or worsening of anorexia, disorientation, dependence.</p><p>The CBSU is said to be positive if:</p><p>* with no catheterization: leukocyturia &gt; 105 CFU /ml with 1 or 2 species of bacteria on culture, * with round-trip catheterization: leukocyturia &gt; 102 CFU /ml with 1 or more species of bacteria on culture [<xref ref-type="bibr" rid="scirp.109366-ref11">11</xref>].</p><p>- Urinary colonization or asymptomatic bacteriuria: this is the presence of a microorganism in the urine without associated clinical manifestations. There is no bacteriuria threshold, except in pregnant women, where a bacteriuria threshold of 105 CFU/ml is classically used.</p><p>Elderly patient: any person over 65 years of age, whether retired, able-bodied or disabled with at least 3 criteria of frailty or over 75 years of age [<xref ref-type="bibr" rid="scirp.109366-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref13">13</xref>].</p><p>- Nosocomial urinary tract infections or hospital-acquired infections: urinary tract infections acquired during a hospital stay and which were neither present nor incubating at the time of the patient’s admission. They occur more than 48 hours after admission and are usually considered nosocomial [<xref ref-type="bibr" rid="scirp.109366-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref15">15</xref>].</p><p>Community-acquired urinary tract infections: urinary tract infections acquired in the city at a distance from any hospital or therapeutic stay. They manifest themselves in less than 48 hours after hospitalization.</p><p>- Recurrent cystitis: they are defined by the occurrence of at least 4 episodes during 12 consecutive months [<xref ref-type="bibr" rid="scirp.109366-ref13">13</xref>].</p><p>- Pyelonephritis: microbial inflammation of the pelvis associated with invasion of the interstitium by suppurative streaks. It can be primary (without urological lesions) or secondary (following a uropathy or an obstacle), acute or chronic.</p><p>- Simple urinary tract infections: urinary tract infection (UTI) occurring in patients with no risk factors for complications [<xref ref-type="bibr" rid="scirp.109366-ref13">13</xref>].</p><p>- Severe urinary tract infections.</p><p>These are acute pyelonephritis and male UTI associated with:</p><p>- Severe sepsis;</p><p>- Septic shock;</p><p>- An indication for surgical or interventional drainage (risk of aggravation of sepsis in the perioperative period) [<xref ref-type="bibr" rid="scirp.109366-ref13">13</xref>].</p><p>Urinary tract infections at risk of complication: these are UTI occurring in patients with at least one risk factor that can make the infection more serious and the treatment more complex [<xref ref-type="bibr" rid="scirp.109366-ref13">13</xref>]. The risk factors for complication are:</p><p>- Any organic or functional abnormality of the urinary tree (bladder residue, reflux, lithiasis, tumor, recent procedure …).</p><p>- Male gender, because of the frequency of underlying anatomical or functional anomalies.</p><p>- Pregnancy.</p><p>- Elderly subject: patient over 65 years old with &gt;3 criteria of frailty (Fried criteria), or patient over 75 years old.</p><p>- Severe immunodepression.</p><p>- Severe chronic renal failure (clearance &lt; 30 ml/min) [<xref ref-type="bibr" rid="scirp.109366-ref13">13</xref>].</p><p>- Fried criteria:</p><p>- Involuntary weight loss in the past year.</p><p>- Slow walking speed.</p><p>- Low stamina.</p><p>- Weakness/tiredness.</p><p>- Reduced physical activity [<xref ref-type="bibr" rid="scirp.109366-ref13">13</xref>].</p><p>Data entry and analysis were performed using Microsoft WORD 2007 and SPSS Software version 20.0. For the comparison of our proportions we used the Chi-square test with p &lt; 0.05.</p><p>Informed consent was obtained from the patients included in our study. In case of major disability, the consent of the family was requested. The anonymity and confidentiality of the results were assured.</p></sec><sec id="s3"><title>3. Results</title><p>We collected and examined 194 patients according to our inclusion criteria during the study period. The CBSU was positive in 28 patients, a prevalence of 14.43%. The male sex represented 59.8% of the cases, with a sex ratio of 1.46. The average age was 69 &#177; 2 years. The age groups between 65 - 69 and 70 - 74 years were the most affected, respectively 28.57% and 39.28%.</p><p>The main clinical signs were: physical asthenia, anorexia, dependence, fever, urinary burning, dysuria. They were more marked in hospital than in the outpatient setting (Cf. <xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Hospitalization was associated with urinary tract infection with p = 0.01 (Cf. <xref ref-type="table" rid="table2">Table 2</xref>). It occurred in patients with the following comorbidities: HTA (10 cases), Liver cancer (5 cases) cirrhosis (7 cases), diabetes (7 cases) and heart failure (6 cases). Urinary tract infections were represented by pyelonephritis, acute prostatitis, orchi-epididymitis and simple cystitis. Trans-urethral urinary catheterization was associated with urinary tract infection with p &lt; 0.005 (Cf. <xref ref-type="table" rid="table3">Table 3</xref>). Enterobacteriaceae was incriminated in 75% of cases. Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa accounted for 39.28%, 14.28% and 10.71% of the cases (see <xref ref-type="table" rid="table4">Table 4</xref>). Of the 28 cases of confirmed UTIs, 22 were hospitalized with 14 males and 8 females, and Escherichia coli represented 41% of the germs found. In outpatient settings, urinary tract infection was more frequent in women (4 cases) with 33.3% of E. Coli. Trans-urethral urinary catheterization and Escherichia coli were respectively the most common factors for urinary tract infection (18 cases/28) and the most common germ isolated by cytobacteriological examination of urine (11 cases). Prostatic obstruction and diabetes were the other factors responsible for the frequent presence of Escherichia Coli in our study. All the germs found at the CBSU had in common the presence of a trans-urethral urinary catheter (Cf. <xref ref-type="table" rid="table5">Table 5</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of 28 patients with urinary tract infection according to symptomatology and origin</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Symptoms</th><th align="center" valign="middle" >Outpatient</th><th align="center" valign="middle" >Hospitalization</th><th align="center" valign="middle" >Total</th></tr></thead><tr><td align="center" valign="middle" >Pollakiuria</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >11</td></tr><tr><td align="center" valign="middle" >Burning of the bladder</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >15</td></tr><tr><td align="center" valign="middle" >Dysuria</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >12</td></tr><tr><td align="center" valign="middle" >Pelvic pain</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >9</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >14</td></tr><tr><td align="center" valign="middle" >Gross hematuria</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Low back pain</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >Urinary incontinence</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >11</td></tr><tr><td align="center" valign="middle" >Fiver</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >16</td></tr><tr><td align="center" valign="middle" >Hypothermia</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >Thrill</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >Confusion</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >Fall</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >Anorexia</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >22</td></tr><tr><td align="center" valign="middle" >Asthenia</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >23</td></tr><tr><td align="center" valign="middle" >Karnofsky dependency &lt; 45%.</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >18</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of patients according to their origin and urinary infections</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Outpatient</th><th align="center" valign="middle" >Hospitalization</th><th align="center" valign="middle" >Total</th></tr></thead><tr><td align="center" valign="middle" >Presence of UTI</td><td align="center" valign="middle" >6 (3.09%)</td><td align="center" valign="middle" >22 (11.34%)</td><td align="center" valign="middle" >28 (14.43%)</td></tr><tr><td align="center" valign="middle" >Absence of UTI</td><td align="center" valign="middle" >78 (40.21%)</td><td align="center" valign="middle" >88 (45.36%)</td><td align="center" valign="middle" >166 (85.57%)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84 (43.30%)</td><td align="center" valign="middle" >110 (56.70%)</td><td align="center" valign="middle" >194 (100%)</td></tr></tbody></table></table-wrap><p>p = 0.01.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of patients according to the trans-urethral urinary catheter and urinary infection</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Urinary catheterization</th><th align="center" valign="middle" >Presence of UTI</th><th align="center" valign="middle" >Absence of UTI</th><th align="center" valign="middle" >Total</th></tr></thead><tr><td align="center" valign="middle" >Presence of a survey</td><td align="center" valign="middle" >18 (9.28%)</td><td align="center" valign="middle" >10 (5.15%)</td><td align="center" valign="middle" >28 (14.43%)</td></tr><tr><td align="center" valign="middle" >Absence of survey</td><td align="center" valign="middle" >10 (5.15%)</td><td align="center" valign="middle" >156 (84.42%)</td><td align="center" valign="middle" >166 (85.57%)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >28 (14.43%)</td><td align="center" valign="middle" >166 (85.57%)</td><td align="center" valign="middle" >194 (100%)</td></tr></tbody></table></table-wrap><p>p &lt; 0.005.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of bacteria responsible for infections according to their morphology and group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Morphology</th><th align="center" valign="middle" >Groupe</th><th align="center" valign="middle" >Group frequency</th><th align="center" valign="middle" >Groupe %</th><th align="center" valign="middle" >Species</th><th align="center" valign="middle" >Group frequency</th><th align="center" valign="middle" >Species %</th></tr></thead><tr><td align="center" valign="middle"  rowspan="7"  >Gram negative bacilli</td><td align="center" valign="middle"  rowspan="7"  >Enterobacteria</td><td align="center" valign="middle"  rowspan="7"  >21</td><td align="center" valign="middle"  rowspan="7"  >75%</td><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >39.28%</td></tr><tr><td align="center" valign="middle" >Klebsiella pneumoniae</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >14.28%</td></tr><tr><td align="center" valign="middle" >Pseudomonas aeruginosa</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >10.71%</td></tr><tr><td align="center" valign="middle" >Acinetobacter sp</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.57%</td></tr><tr><td align="center" valign="middle" >Enterobacter cloacae</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.57%</td></tr><tr><td align="center" valign="middle" >Proteus mirabilis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.57%</td></tr><tr><td align="center" valign="middle" >Streptococcus sp</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >10.71%</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Gram positive cocci</td><td align="center" valign="middle" >Streptococci</td><td align="center" valign="middle" >5</td><td align="center" valign="middle"  rowspan="3"  >25%</td><td align="center" valign="middle" >Streptococcus non groupable</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >7.14%</td></tr><tr><td align="center" valign="middle" >Staphylococci</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Staphylococcus &#224; coagulas n&#233;gatif</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.57%</td></tr><tr><td align="center" valign="middle" >Enterococci</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Enterococcus</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.57%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of the 28 patients according to the factors favouring urinary tract infection and the germs isolated</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Bacteria</th><th align="center" valign="middle" >Diabetes</th><th align="center" valign="middle" >Urinary catheter</th><th align="center" valign="middle" >Prostate adenoma</th><th align="center" valign="middle" >Total</th></tr></thead><tr><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >11</td></tr><tr><td align="center" valign="middle" >Klebsiella pneumoniae</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Pseudomonas aeruginosa</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >Streptococcus sp</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >Streptococcus non groupable</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >Acinotobacter sp</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Proteus mirabilis</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Staphylococcus &#224; coagulase negatif</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Enteroccus foecalis</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Enterobacter cloacae</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >28</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>Of the 276 patients seen during the study period, 194 met the inclusion criteria, of whom 28 CBSU were positive, i.e. a prevalence of 14.43%. This high prevalence of hospital-acquired UTIs in our series could be explained by the frequent recruitment of patients who had stayed in the emergency department and had been subject to repeated urinary catheterization. Besma Ben Dhaou Hmaidi in Tunisia, Maxwell in Morocco and Traor&#233; in the nephrology department of the university hospital center of Point G reported respective prevalences of 16.6%, 17.49% and 15.6% [<xref ref-type="bibr" rid="scirp.109366-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref16">16</xref>]. The male sex represented 59.8% of the cases, with a sex ratio of 1.46. Our results are in agreement with those of Maxell in Rabat who found a male predominance of 56.4%, with a sex ratio of 1.29 [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>].</p><p>On the other hand, the male predominance was not found by some authors; in Tunisia, Besma Ben Dhaou Hmaidi et al. [<xref ref-type="bibr" rid="scirp.109366-ref2">2</xref>] reported a sex ratio F/H of 0.35; at the University Hospital of Montpellier [<xref ref-type="bibr" rid="scirp.109366-ref17">17</xref>], in the department of internal medicine and acute geriatric care, the proportion of male cases was 1.46 is 2 to 3 women for every man; and it was 2 women for every man in subjects over 65 years old in Paris [<xref ref-type="bibr" rid="scirp.109366-ref18">18</xref>]. The age groups between 65 - 69 and 70 - 74 years were the most affected, with 28.57% and 39.28% respectively. Maxwel found in his study a total of 56.4% with an equal frequency of 28.2% for the two age groups 65 - 70 years and 70 - 75 years [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>]. The clinical symptoms were dominated by dependence (85%), asthenia (82.14%), anorexia (81.48%), fever (57.14%), urinary burning (53.57%), vomiting (50%), chills (35.71%), pollakiuria (39.28%), urinary incontinence (39.28%), lumbar and pelvic pain (32.14%). These signs highlight the polymorphism of symptoms encountered in the elderly during urinary tract infections, and the misleading aspect of certain symptoms. Several studies report the atypical nature of UTI symptoms in the elderly [<xref ref-type="bibr" rid="scirp.109366-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref22">22</xref>].</p><p>Hospitalization was associated with UTI with p = 0.01, but not with length of hospitalization (p = 0.49). This finding corroborates that reported in the literature [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref23">23</xref>].</p><p>The analysis of the history shows that UTI was more frequent in patients with the following pathologies: Hypertension (10 cases), Liver cancer (5 cases) cirrhosis (7 cases), diabetes (7 cases) and IC (6 cases). Concerning the antecedents or risk factors, we find ourselves in a polymorphic context with age and no factor is incriminated with certainty.</p><p>With advanced age, the elderly person accumulates functional fragility and numerous pathologies other than urological (diabetes, non-acquired immunodepression) which may favor urinary infection [<xref ref-type="bibr" rid="scirp.109366-ref14">14</xref>]. UTI are more frequent in inpatients 20% (22/110) than in outpatients 7.14% (6/84) p = 0.01. Maxwel found UTI rates in inpatients and outpatients to be 10.31% and 7.18% respectively [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>].</p><p>In 2009, De Wazi&#232;res reported that nosocomial urinary tract infection increases with advancing age as does bacteriuria, unlike community-acquired UTI which are a frequent reason for consultation and medical prescription in routine practice [<xref ref-type="bibr" rid="scirp.109366-ref24">24</xref>]. In general, urinary tract infections seem to be more frequent in the elderly and in hospitals [<xref ref-type="bibr" rid="scirp.109366-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>]. Urinary tract infection was more frequent in patients with urinary catheters: 64.29% (18/28) than in those without catheters (6.02%), with a statistically significant difference (p = 0.005). Maxwel in Rabat found few urinary tract infections in subjects with urinary catheters. This is probably due to good compliance of the medical services with the recommendations for urinary catheterization [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>]. Our study shows a frequency of urinary tract infections in hospitalized patients, but it is not related to the length of hospitalization (p = 0.49). This finding has been made by other authors [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref23">23</xref>].</p><p>As for the germs isolated, Gram-negative bacilli (GNB) were the most frequently identified in the culture media during our study, with Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeroginosa in the lead. This has also been found in several international series [<xref ref-type="bibr" rid="scirp.109366-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref26">26</xref>]. From the review of the literature, it appears that BGN are frequently encountered in bacteriuria [<xref ref-type="bibr" rid="scirp.109366-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref24">24</xref>] - [<xref ref-type="bibr" rid="scirp.109366-ref30">30</xref>].</p><p>Among the enterobacteria (gram bacille negatif) in our study, Escherichia coli was the most incriminated and isolated in 39.28% cases. In Tunisia in 2011, this bacterium was isolated in 58% of cases [<xref ref-type="bibr" rid="scirp.109366-ref2">2</xref>].</p><p>At the Mohamed V Military Hospital in Rabat in 2014, it was isolated in 59% of cases [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>]. For our study E. coli was followed by Klebsiella pneumoniae 14.28% and Pseudomonas aeroginosa 10.71%, Streptococcus sp 10.71%, for the rest, we isolated 3.57% of Acinobacter Sp, Proteus mirabilisof coagulase-negative Staphylococcus, Entrococcus faecalis and Enterobacter cloacae.</p><p>In the literature, E. coli is the most incriminated in UTI [<xref ref-type="bibr" rid="scirp.109366-ref24">24</xref>]. According to the SPLIF 2014, E. coli is the most frequently encountered bacterium (70% - 95%) in community-acquired UTIs. It is followed by the other enterobacteria especially Proteus sp. and Klebsiella sp [<xref ref-type="bibr" rid="scirp.109366-ref13">13</xref>].</p><p>Faucher N and Cudenne T. in Paris found that E. coli is more frequent in elderly women in the community and in hospitals. On the other hand, in elderly men, E. coli is more frequent in the community; in the hospital, Proteus mirabilis is the most frequent [<xref ref-type="bibr" rid="scirp.109366-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.109366-ref31">31</xref>].</p><p>The frequency of Pseudomonas aeruginosa: 4.8% is similar to that found in a retrospective study of UTI at the Mohamed V Military Hospital in Rabat in 2013 [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>].</p><p>For Gram-positive cocci in our study, we found the following proportions: 10.71% for Streptococcus sp and 3.57% for non-groupable Streptococcus and coagulase-negative Staphylococcus. Maxwel reported for Gram-positive cocci a frequency of: 4.8%, for Enterococcus faecalis and for group B Streptococcus; and 1.2% for coagulase-negative Staphylococcus was low [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>]. The antibiotic susceptibility of the isolated germs was variable, thus Escherichia coli was resistant to amoxicillin (81.81%); to amoxicillin + clavulanic acid (45.45%). It was sensitive to ceftazidine (72.72%), cefoxitine (81.81%), imipenem (81.81%), amikacin (90.90%), gentamicin (72.72%), ciprofloxacin (54.54%), nalidixic acid (45.45%), chloramphenicol (81.81%), sulphamethoxazole + trimethoprim (27.27%) and colistin (100%). Traor&#233; et al. reported in a study in 2012 a sensitivity of E coli to 89%; amikacin, colistin and doxycycline to 88.2% each [<xref ref-type="bibr" rid="scirp.109366-ref32">32</xref>]. According to Alami et al., E. coli had a sensitivity rate of 99% for fosfomycin, colistin, amikacin, cefoxitin and imipenem [<xref ref-type="bibr" rid="scirp.109366-ref33">33</xref>]. The same author reports resistance rates of 76% for amoxicillin, 54% for amoxicillin + clavulanic acid, 46% for 1st generation cephalosporins (C1G), 34% for Ciprofloxacin, 19% for 3rd generation cephalosporins (C3G) and 14% for aminoglycosides. E. coli resistance to antibiotics has become an alarming problem in Morocco. This situation is the consequence of the selection pressure due to the massive prescription and the often abusive use of broad spectrum antibiotics, both in hospital and in community settings [<xref ref-type="bibr" rid="scirp.109366-ref33">33</xref>].</p><p>According to De Mouy et al., the resistance rates of E. coli in community urinary tract infections were as follows: ampicillin (60.5%), amoxicillin + clavulanic acid (65.9%), gentamicin (98.8%), nalidixic acid (93.4%), norfloxacin (97%), ciprofloxacin (97%), fosfomycin (99.3%), and cotrimoxazole (77.4%) [<xref ref-type="bibr" rid="scirp.109366-ref34">34</xref>].</p><p>Comparing these rates with those of our work, we notice that our E. coli strains are more resistant to betalactam and also present a decreased sensitivity to gentamicin, nalidixic acid, ciprofloxacin and cotrimoxazole. Esparcia et al. in a European study reported E. coli strains with zero susceptibility to imipenem and 33.5% to sulfamethoxazole + Trimethoprim [<xref ref-type="bibr" rid="scirp.109366-ref35">35</xref>]. Here, we note that our E. coli species are more sensitive to colistin.</p><p>In France, in the elderly in 2013, the authors reported a sensitivity of E. coli to fosfomycin at 95% [<xref ref-type="bibr" rid="scirp.109366-ref36">36</xref>].</p><p>Klebsiella pneumoniae strains were sensitive to cefoxitin (75%), imipenem (66.66%), ceftazidime (75%), amikacin (75%), gentamicin (66.66%), chloramphenicol (75%) and colistin (100).</p><p>For Maxwel et al. Klebsiella pneumoniae strains were sensitive to cefoxitin (76.92%), ertapenem (75%), imipenem (75%), ceftriaxone (64.29%) ceftazidime (64.29%), amikacin (93.33%), tobramycin (73.33%), gentamicin (66.67%), fosfomycin (93.33%), colistin and chloramphenicol (100%) [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>].</p><p>Alami et al. reported for Klebsiella pneumoniae, a very high sensitivity rate for C3G and aminoglycosides (99%) and for piperacillin and amoxicillin + clavulanic acid (50%) [<xref ref-type="bibr" rid="scirp.109366-ref34">34</xref>]. Traor&#233; et al. reported a sensitivity of Klebsiella pneumoniae to colistin (94.1%); cefoxitin (81.3%); amikacin (78.6%) [<xref ref-type="bibr" rid="scirp.109366-ref37">37</xref>]. On the other hand, our study found that the strains are resistant to amoxicillin (100%); amoxicillin + clavulanic acid (66.66%) and ciprofloxacin (33.33%).</p><p>In the study by Maxwel et al. Klebsiella pneumoniae strains were resistant to amoxicillin + clavulanic acid and piperacillin (80%), cefalotin (53.33%), nalidixic acid (66.67%), sulfamethoxazole + trimethoprim and norfloxacin (60%).</p><p>In the elderly in France in 2014, Thibaut et al. recorded a sensitivity of Klebsiella pneumoniae strains to fosfomycin at 75%, cotrimoxazole at 35%, ciprofloxacin at 26% and nalidixic acid at 19% [<xref ref-type="bibr" rid="scirp.109366-ref36">36</xref>].</p><p>For Pseudomonas aeruginosa, the results of our study show that the strains of Pseudomonas aeruginosa were sensitive to ceftazidime, amikacin and colistin at 100%.</p><p>For Moumile et al. the strains of P. aeruginosa were sensitive to ceftazidime and resistant to ciprofloxacin [<xref ref-type="bibr" rid="scirp.109366-ref23">23</xref>]. According to Maxwel et al., Pseudomonas aeruginosa strains were sensitive to beta-lactams (imipenem, aztreonam, ceftazidime, cefepime and ticarcillin + clavulanic acid at 100% and to ticarcillin, piperacillin and piperacillin + tazobactam at 75%), aminoglycosides (gentamicin, tobramycin and amikacin at 75%, netilmicin at 33.33%), and ciprofloxacin (100%) [<xref ref-type="bibr" rid="scirp.109366-ref10">10</xref>]. According to Filali et al., the most active β-lactams on Pseudomonas Aeruginosa are ceftazidime and imipenem. Amikacin was more active than gentamycin and almost 39% of the strains were resistant to ciprofloxacin [<xref ref-type="bibr" rid="scirp.109366-ref38">38</xref>].</p></sec><sec id="s5"><title>5. Study Limitations</title><p>- The diagnosis of the urinary tract infection could not be made within 48 hours to allow us to distinguish between community and nosocomial infection.</p><p>- The distinction between simple and complicated urinary tract infection (parenchymal involvement) was not specified.</p><p>- Our sample size was relatively small and CBSU was not systematically performed.</p><p>- The inclusion criteria are based on the signs of call, thus underestimating the asymptomatic forms.</p></sec><sec id="s6"><title>6. Conclusion</title><p>UTI is common in the elderly, its clinical presentation is polymorphic, and enterobacteria are the most incriminated group of bacteria.</p></sec><sec id="s7"><title>Acknowledgements</title><p>We thank all the staff of the hospital of Kayes, the CHU Point G and the Mali-GAVARDO hospital of S&#233;benicoro.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Sangar&#233;, D., Samak&#233;, M., Doumbia, N., Fofana, A.S., Ciss&#233;, S.M., Sy, S., Kodio, A., Coulibaly, M., dit Baba Coulibaly, S., Sy, D., Soucko, K.A., Demb&#233;l&#233;, M. and Fongoro, S. (2021) Profile of Urinary Tract Infections in the Elderly in the Internal Medicine Department of the University Hospital Center of Point G, Bamako, Mali. Open Journal of Nephrology, 11, 217-229. https://doi.org/10.4236/ojneph.2021.112017</p></sec></body><back><ref-list><title>References</title><ref id="scirp.109366-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Bendhaouhmaidi, B., Boussema, F. and Ketari, S. (2011) Les infections urinaires chez les personnes &amp;acire;gées. La Revue francophone de gériatrie et de gérontologie, 18, 230-232.</mixed-citation></ref><ref id="scirp.109366-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Hmaidi, B.B.D., Boussema, F., Aydi, Z., Baili, L., Ketari, S., Rhouma, S.B., et al. (2011) Les infections urinaires (IU) du sujet &amp;acire;gé. La Tunisie Medicale, 89, 920-923.</mixed-citation></ref><ref id="scirp.109366-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Gavazzi, G., Delerce, E., Cambau, E., Franois, P., Corroyer, B., de Wazières, B., et al. (2013) Diagnostic Criteria for Urinary Tract Infection in Hospitalized Elderly Patients over 75 Years of Age: A Multicenter Cross-Sectional Study. Médecine et Maladies Infectieuses, 43, 189-194. https://doi.org/10.1016/j.medmal.2013.02.006</mixed-citation></ref><ref id="scirp.109366-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Boscia, J.A., Kobasa, W.D., Knight, R.A., et al. (1986) Epidemiology of Bacteriuria in an Elderly Ambulatory Population. The American Journal of Medicine, 80, 208-214. https://doi.org/10.1016/0002-9343(86)90011-2</mixed-citation></ref><ref id="scirp.109366-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Nicolle, L.E. (2009) Urinary Tract Infections in the Elderly. Clinics in Geriatric Medicine, 25, 423-436. https://doi.org/10.1016/j.cger.2009.04.005</mixed-citation></ref><ref id="scirp.109366-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Foxman, B. (2002) Epidemiology of Urinary Tract Infection: Incidence, Morbidity and Economic Cost. The American Journal of Medicine, 113, 5-13. https://doi.org/10.1016/S0002-9343(02)01054-9</mixed-citation></ref><ref id="scirp.109366-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Phillips, C.D., Adepoju, O., Stone, N., et al. (2012) Asymptomatic Bacteriuria, Antibiotic Use, and Suspected Urinary Tract Infections in Four Nursing Homes. BMC Geriatrics, 12, Article No. 73. https://doi.org/10.1186/1471-2318-12-73</mixed-citation></ref><ref id="scirp.109366-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Schmiemann, G., Kniehl, E., Gebhardt, K., et al. (2010) The Diagnosis of Urinary Tractinfection: A Systematic Review. Deutsches &amp;Auml;rzteblatt International, 107, 361-367. https://doi.org/10.3238/arztebl.2010.0361</mixed-citation></ref><ref id="scirp.109366-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Wagenlehner, F.M., Weidner, W., Pilatz, A. and Naber, K.G. (2014) Urinary Tract Infections and Bacterial Prostatitis in Men. Current Opinion in Infectious Diseases, 27, 97-101. https://doi.org/10.1097/QCO.0000000000000024</mixed-citation></ref><ref id="scirp.109366-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Sampson, M.M. (2015) Infection urinaire chez le sujet &amp;acire;gé &amp;agrave; l’H&amp;ocirc;pital Militaire d’Instruction Mohamed V de Rabat. Thèses de pharmacie, Maroc, 03.</mixed-citation></ref><ref id="scirp.109366-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">McGeer, A., Campbell, B., Emori, T.G., Hierholzer, W.J., Jackson, M.M., Nicolle, L.E., et al. (1991) Definitions of Infection for Surveillance in Long-Term Care Facilities. American Journal of Infection Control, 19, 1-7. https://doi.org/10.1016/0196-6553(91)90154-5</mixed-citation></ref><ref id="scirp.109366-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Delamare, V. and Garnier, M. (2006) Définition de la personne &amp;acire;gée. In: Dictionnaire des termes de médecine, 29th Edition, Maloine, Paris.</mixed-citation></ref><ref id="scirp.109366-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Caron, F. (2014) Société de Pathologie Infectieuse de Langue Franaise. Mise au point. Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires de l’adulte. http://www.infectiologie.com/site/medias/Recos/2014-infections_urinaires-court.pdf</mixed-citation></ref><ref id="scirp.109366-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Agence Franaise de Sécurité Sanitaire des Produits de Santé (2008) Recommandations de bonne pratique: Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires chez l’adulte. http://www.infectiologie.com/site/medias/_documents/consensus/afssaps-inf-urinaires-adulte-argumentaire.pdf</mixed-citation></ref><ref id="scirp.109366-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Collège des Universitaires des Maladies Infectieuses et Tropicales (CMIT) (2012) Anti-infectieux: Antibiotiques. ePilly TROP: Maladies infectieuses et tropicales. 22th Edition, Vivactis Plus Ed, 44-57. http://www.infectiologie.com/site/medias/enseignement/ePillyTROP/ePillyTROP.pdf</mixed-citation></ref><ref id="scirp.109366-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Traoré, H. (2006) Les infections urinaires dans le service de néphrologie et d’hémodialyse de l’h&amp;ocirc;pital du point G. These Med, Bamako, 206.</mixed-citation></ref><ref id="scirp.109366-ref17"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raschilas</surname><given-names> F. </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>Epidémiologie des maladies infectieuses du sujet &amp;acire;gé</article-title><source> Soins Gérontologie</source><volume> 61</volume>,<fpage> 4</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.109366-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Cédric, C. and Régis, G. (2012) Infection urinaire du sujet &amp;acire;gé. Rev Geriatr A, 37, 119-128.</mixed-citation></ref><ref id="scirp.109366-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Delamonica, M.C. and Chatelier, F.J. (1997) Particularités de l’infection urinaire du sujet &amp;acire;gé. Rev Geriatr, 2, 597-600.</mixed-citation></ref><ref id="scirp.109366-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Tristan, C., Catherine, C. and Nathalie, F. (2004) Prise en charge d’une infection urinaire chez le sujet &amp;acire;gé. Soins Gérontologie A, 47, 39-42.</mixed-citation></ref><ref id="scirp.109366-ref21"><label>21</label><mixed-citation publication-type="book" xlink:type="simple">De Wazières, B. and Rainfray, M. (2009) Infections urinaires du sujet &amp;acire;gé. In: Belmin, J., Ed., Gériatrie pour le praticien, 2nd Edition, Masson, Paris, 367-369.</mixed-citation></ref><ref id="scirp.109366-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Rapport d’activité 2008. ONERBA, Décembre 2010, p.112 http://www.onerba.org/IMG/pdf/onerba_rapport2008_LD.pdf</mixed-citation></ref><ref id="scirp.109366-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Moumile, K., Carbonne, A., Rouquet, M.-L., Gamard, M.-N., et al. (2004) étude descriptive des bactériémies dans un h&amp;ocirc;pital gériatrique universitaire. Pathologie Biologie, 52, 557-565. https://doi.org/10.1016/j.patbio.2004.07.040</mixed-citation></ref><ref id="scirp.109366-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Christophe, T., Fabienne, L.-T. and Catherine, M. (2006) écologie bactérienne des prélèvements urinaires: Intérêt dans le choix de l’antibiothérapie probabiliste des infections urinaires du sujet &amp;acire;gé hospitalisé. La Rev Gér A, 31, 77-82.</mixed-citation></ref><ref id="scirp.109366-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Delerge, E. (2014) Etude des bactériuries du sujet &amp;acire;gé hospitalisé: Critères cliniques déterminant les diagnostics d’infection. Thes Med, Université de Grenoble, Grenoble, 312. http://dumas.ccsd.cnrs.fr/dumas-00628102</mixed-citation></ref><ref id="scirp.109366-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Akpabie, A. and Prieur, B. (2001) Germes urinaires et leur sensibilité aux antibiotiques en gériatrie. Médecine et Maladies Infectieuses, 31, 461-467. https://doi.org/10.1016/S0399-077X(01)00247-5</mixed-citation></ref><ref id="scirp.109366-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Bathily Diarra, M. (2002) Sensibilité aux antibiotiques des bactéries &amp;agrave; gram négatif isolées d’infections urinaires &amp;agrave; l’H&amp;ocirc;pital National du Point G. These Pharm, Bamako, 46.</mixed-citation></ref><ref id="scirp.109366-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Epok, J.C. (1998) Aspects épidémiologiques et étiologiques des infections urinaires &amp;agrave; l’h&amp;ocirc;pital national du Point G. These Pharm, Bamako, 5.</mixed-citation></ref><ref id="scirp.109366-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Hsueh, P.R., Hoban, D.J., Carmeli, Y., Chen, S.Y., Desikan, S., Alejandria, M., et al. (2011) Consensus Review of the Epidemiology and Appropriate Antimicrobial Therapy of Complicated Urinary Tract Infections in Asia-Pacific Region. The Journal of Infection, 63, 114-123. https://doi.org/10.1016/j.jinf.2011.05.015</mixed-citation></ref><ref id="scirp.109366-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Siby, F.B. (1992) Etude clinique, bactériologique et thérapeutique des infections urinaires dans les services de Médecine interne de l’h&amp;ocirc;pital national du Point G. These Med, Bamako, 18.</mixed-citation></ref><ref id="scirp.109366-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Faucher, N. and Billebaud, T. (2000) Les infections urinaires du sujet &amp;acire;gé. Rev Gér, 25, 507-513.</mixed-citation></ref><ref id="scirp.109366-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Traoré, A.M., Minta, D.K., Cissé, H., Coulbaly, I., Niaré, B., Diallo, I., et al. (2012) Current Epidemiological and Bacteriological Profile of Urinary Tract Infections in the Infectious Diseases Department of the Point G University Hospital, Bamako. Mali. Rev. CAMES-Series A, 13, 122-126.</mixed-citation></ref><ref id="scirp.109366-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Alami, M., Filali, A., Lahlou, H. and Mahmoud, M. (2011) Resistance Profile of Escherichia coli Strains Isolated from Urine at Hassan II University Hospital in Fez. Microbiology Laboratory. 4th Scientific Day, CHU Hassan II, Fez.</mixed-citation></ref><ref id="scirp.109366-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">De Mouy, D., Fabre, R., Cavallo, J.-D., et al. (2007) Community-Acquired Urinary Tract Infections in 15 to 65 Years Old Female Patients in France. Susceptibility of E. coli According to History: AFORCOPI-BIO Network 2003. Médecine et Maladies Infectieuses, 37, 594-598. https://doi.org/10.1016/j.medmal.2006.11.007</mixed-citation></ref><ref id="scirp.109366-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Esparcia, A., Artero, A., Eiros, J.M., Balaguer, M., Madrazo, M., et al. (2014) Influence of Adequate Antimicrobial Therapy on Prognosis in Elderly Patients with Severe Urinary Tract Infections. European Journal of Internal Medicine, 25, 523-527. https://doi.org/10.1016/j.ejim.2014.04.009</mixed-citation></ref><ref id="scirp.109366-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Thibaut, S., Caillon, J., Marquet, A., Grandjean, G., Potel, G., Ballereau, F. and Microbiology Laboratories of the MedQual Network (2014) Epidemiology of Third-Generation Cephalosporin-Resistant Community Acquired Enterobacteria Isolated from Elderly Patients. Médecine et Maladies Infectieuses, 44, 57-62. https://doi.org/10.1016/j.medmal.2013.11.008</mixed-citation></ref><ref id="scirp.109366-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Traoré, A.M., Minta, D.K., Cissé, H., Kaya-Soukho, A., Coulbaly, I., Diallo, K., Fomba, M., et al. (2012) Nosocomial Urinary Tract Infections, Place of Klebsiella pneumoniae in the Infectious Diseases Department of the CHU du Point G. Bamako. Rev. CAMES-Series A, 13, 118-121.</mixed-citation></ref><ref id="scirp.109366-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Filali Baba, A., Alami, M., Lahlou, H., Yahyaoui, Gh. and Mahmoud, M. (2011) Epidemiology and Resistance Profile of Urinary Tract Infections with Pseudomonas aeruginosa. Microbiology Laboratory, 4th Scientific Day, CHU Hassan II, Fez.</mixed-citation></ref></ref-list></back></article>